Frontline therapy with bendamustine rituximab (BR) and rituximab cyclophosphamide vincristine prednisone (RCVP) confers similar long-term outcomes in patients with treatment naïve Waldenström macroglobulinemia in a real-world setting: a population-based analysis.

Saved in:
Bibliographic Details
Title: Frontline therapy with bendamustine rituximab (BR) and rituximab cyclophosphamide vincristine prednisone (RCVP) confers similar long-term outcomes in patients with treatment naïve Waldenström macroglobulinemia in a real-world setting: a population-based analysis.
Authors: Kim JL; UBC, Department of Medicine, Vancouver, Canada., Gerrie AS; BC Cancer Agency, Centre for Lymphoid Cancer and Department of Medical Oncology, Vancouver, Canada., Savage KJ; BC Cancer Agency, Centre for Lymphoid Cancer and Department of Medical Oncology, Vancouver, Canada., Villa D; BC Cancer Agency, Centre for Lymphoid Cancer and Department of Medical Oncology, Vancouver, Canada., Scott D; BC Cancer Agency, Centre for Lymphoid Cancer and Department of Medical Oncology, Vancouver, Canada., Craig JW; BC Cancer Agency, Centre for Lymphoid Cancer and Department of Pathology, Vancouver, Canada., Farinha P; BC Cancer Agency, Centre for Lymphoid Cancer and Department of Pathology, Vancouver, Canada., Skinnider B; BC Cancer Agency, Centre for Lymphoid Cancer and Department of Pathology, Vancouver, Canada., Slack G; BC Cancer Agency, Centre for Lymphoid Cancer and Department of Pathology, Vancouver, Canada., Connors JM; BC Cancer Agency, Centre for Lymphoid Cancer and Department of Medical Oncology, Vancouver, Canada., Sehn LH; BC Cancer Agency, Centre for Lymphoid Cancer and Department of Medical Oncology, Vancouver, Canada., Venner C; BC Cancer Agency, Centre for Lymphoid Cancer and Department of Medical Oncology, Vancouver, Canada., Freeman CL; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL, USA.
Source: Leukemia & lymphoma [Leuk Lymphoma] 2024 Mar; Vol. 65 (3), pp. 346-352. Date of Electronic Publication: 2023 Dec 29.
Publication Type: Journal Article
Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38156444
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Frontline therapy with bendamustine rituximab (BR) and rituximab cyclophosphamide vincristine prednisone (RCVP) confers similar long-term outcomes in patients with treatment naïve Waldenström macroglobulinemia in a real-world setting: a population-based analysis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Kim+JL%22">Kim JL</searchLink>; UBC, Department of Medicine, Vancouver, Canada.<br /><searchLink fieldCode="AU" term="%22Gerrie+AS%22">Gerrie AS</searchLink>; BC Cancer Agency, Centre for Lymphoid Cancer and Department of Medical Oncology, Vancouver, Canada.<br /><searchLink fieldCode="AU" term="%22Savage+KJ%22">Savage KJ</searchLink>; BC Cancer Agency, Centre for Lymphoid Cancer and Department of Medical Oncology, Vancouver, Canada.<br /><searchLink fieldCode="AU" term="%22Villa+D%22">Villa D</searchLink>; BC Cancer Agency, Centre for Lymphoid Cancer and Department of Medical Oncology, Vancouver, Canada.<br /><searchLink fieldCode="AU" term="%22Scott+D%22">Scott D</searchLink>; BC Cancer Agency, Centre for Lymphoid Cancer and Department of Medical Oncology, Vancouver, Canada.<br /><searchLink fieldCode="AU" term="%22Craig+JW%22">Craig JW</searchLink>; BC Cancer Agency, Centre for Lymphoid Cancer and Department of Pathology, Vancouver, Canada.<br /><searchLink fieldCode="AU" term="%22Farinha+P%22">Farinha P</searchLink>; BC Cancer Agency, Centre for Lymphoid Cancer and Department of Pathology, Vancouver, Canada.<br /><searchLink fieldCode="AU" term="%22Skinnider+B%22">Skinnider B</searchLink>; BC Cancer Agency, Centre for Lymphoid Cancer and Department of Pathology, Vancouver, Canada.<br /><searchLink fieldCode="AU" term="%22Slack+G%22">Slack G</searchLink>; BC Cancer Agency, Centre for Lymphoid Cancer and Department of Pathology, Vancouver, Canada.<br /><searchLink fieldCode="AU" term="%22Connors+JM%22">Connors JM</searchLink>; BC Cancer Agency, Centre for Lymphoid Cancer and Department of Medical Oncology, Vancouver, Canada.<br /><searchLink fieldCode="AU" term="%22Sehn+LH%22">Sehn LH</searchLink>; BC Cancer Agency, Centre for Lymphoid Cancer and Department of Medical Oncology, Vancouver, Canada.<br /><searchLink fieldCode="AU" term="%22Venner+C%22">Venner C</searchLink>; BC Cancer Agency, Centre for Lymphoid Cancer and Department of Medical Oncology, Vancouver, Canada.<br /><searchLink fieldCode="AU" term="%22Freeman+CL%22">Freeman CL</searchLink>; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229007422%22">Leukemia & lymphoma</searchLink> [Leuk Lymphoma] 2024 Mar; Vol. 65 (3), pp. 346-352. <i>Date of Electronic Publication: </i>2023 Dec 29.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9007422 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1029-2403 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210268022%22">10268022 </searchLink><i>NLM ISO Abbreviation: </i>Leuk Lymphoma <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38156444
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/10428194.2023.2290466
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 346
    Titles:
      – TitleFull: Frontline therapy with bendamustine rituximab (BR) and rituximab cyclophosphamide vincristine prednisone (RCVP) confers similar long-term outcomes in patients with treatment naïve Waldenström macroglobulinemia in a real-world setting: a population-based analysis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Kim JL
      – PersonEntity:
          Name:
            NameFull: Gerrie AS
      – PersonEntity:
          Name:
            NameFull: Savage KJ
      – PersonEntity:
          Name:
            NameFull: Villa D
      – PersonEntity:
          Name:
            NameFull: Scott D
      – PersonEntity:
          Name:
            NameFull: Craig JW
      – PersonEntity:
          Name:
            NameFull: Farinha P
      – PersonEntity:
          Name:
            NameFull: Skinnider B
      – PersonEntity:
          Name:
            NameFull: Slack G
      – PersonEntity:
          Name:
            NameFull: Connors JM
      – PersonEntity:
          Name:
            NameFull: Sehn LH
      – PersonEntity:
          Name:
            NameFull: Venner C
      – PersonEntity:
          Name:
            NameFull: Freeman CL
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 03
              Text: 2024 Mar
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1029-2403
          Numbering:
            – Type: volume
              Value: 65
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Leukemia & lymphoma
              Type: main
ResultId 1